SUFUH anticorps (N-Term)
-
- Antigène Voir toutes SUFUH Anticorps
- SUFUH (Suppressor of Fused Homolog (SUFUH))
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SUFUH est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Specificité
- SUFU Antibody detects endogenous levels of total SUFU.
- Homologie
- Bovine,Horse,Dog,Xenopus
- Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogène
- A synthesized peptide derived from human SUFU, corresponding to a region within N-terminal amino acids.
- Isotype
- IgG
- Top Product
- Discover our top product SUFUH Anticorps primaire
-
-
- Indications d'application
- WB 1:1000-3000, IHC 1:50-1:200, ELISA(peptide) 1:20000-1:40000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
- Date de péremption
- 12 months
-
- Antigène
- SUFUH (Suppressor of Fused Homolog (SUFUH))
- Autre désignation
- SUFU (SUFUH Produits)
- Synonymes
- anticorps CG6054, anticorps Dmel\\CG6054, anticorps SU(FU), anticorps SUFU, anticorps Su(Fu), anticorps SuFu, anticorps Sufu, anticorps su(fu), anticorps sufu, anticorps Xsufu, anticorps sufuh, anticorps sufuxl, anticorps PRO1280, anticorps SUFUH, anticorps SUFUXL, anticorps Su(fu), anticorps dre, anticorps fi39e05, anticorps wu:fi39e05, anticorps 2810026F04Rik, anticorps b2b273Clo, anticorps Suppressor of fused, anticorps SUFU negative regulator of hedgehog signaling L homeolog, anticorps SUFU negative regulator of hedgehog signaling, anticorps suppressor of fused homolog (Drosophila), anticorps Su(fu), anticorps sufu.L, anticorps SUFU, anticorps sufu, anticorps Sufu
- Sujet
-
Description: Negative regulator in the hedgehog/smoothened signaling pathway. Down-regulates GLI1-mediated transactivation of target genes (PubMed:15367681, PubMed:24311597, PubMed:24217340). Down-regulates GLI2-mediated transactivation of target genes (PubMed:24311597, PubMed:24217340). Part of a corepressor complex that acts on DNA-bound GLI1. May also act by linking GLI1 to BTRC and thereby targeting GLI1 to degradation by the proteasome. Sequesters GLI1, GLI2 and GLI3 in the cytoplasm, this effect is overcome by binding of STK36 to both SUFU and a GLI protein (PubMed:10806483, PubMed:24217340). Negative regulator of beta-catenin signaling. Regulates the formation of either the repressor form (GLI3R) or the activator form (GLI3A) of the full-length form of GLI3 (GLI3FL). GLI3FL is complexed with SUFU in the cytoplasm and is maintained in a neutral state. Without the Hh signal, the SUFU-GLI3 complex is recruited to cilia, leading to the efficient processing of GLI3FL into GLI3R. When Hh signaling is initiated, SUFU dissociates from GLI3FL and the latter translocates to the nucleus, where it is phosphorylated, destabilized, and converted to a transcriptional activator (GLI3A). Required for normal embryonic development. Required for the proper formation of hair follicles and the control of epidermal differentiation (By similarity).
Gene: SUFU
- Poids moléculaire
- 54 kDa
- ID gène
- 51684
- UniProt
- Q9UMX1
- Pathways
- Signalisation Hedgehog, Tube Formation, Maintenance of Protein Location
-